Home > News > Pharmaceutical industry looks to commercial metathesis 13th February 2007
February 13th, 2007
Pharmaceutical industry looks to commercial metathesis 13th February 2007
Commercially available metathesis catalysts could provide drugs manufacturers with new opportunities.
Olefin metathesis is one of the most versatile ways of making carbon-carbon bonds and the process has been exploited by petrochemical, polymer, and specialty chemical industries to process simple hydrocarbons for almost 50 years.
China is expected to drive the global nanotechnology and catalysts market this year, a new report claims. Research firm RNCOS predicts that nanoscience will gain huge investment over the next twenty years, bringing about radical changes in the pharmaceutical industry.
Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014
Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014
Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial December 17th, 2014
Unraveling the light of fireflies December 17th, 2014
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Oregon researchers glimpse pathway of sunlight to electricity: Collaboration with Lund University uses modified UO spectroscopy equipment to study 'maze' of connections in photoactive quantum dots December 19th, 2014
Instant-start computers possible with new breakthrough December 19th, 2014
How does enzymatic pretreatment affect the nanostructure and reaction space of lignocellulosic biomass? December 18th, 2014
Iranian Scientists Use Nanotechnology to Increase Power, Energy of Supercapacitors December 18th, 2014